<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="aogs14642" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Acta Obstet Gynecol Scand</journal-id><journal-id journal-id-type="iso-abbrev">Acta Obstet Gynecol Scand</journal-id><journal-id journal-id-type="pmc-domain-id">4315</journal-id><journal-id journal-id-type="pmc-domain">aogs</journal-id><journal-id journal-id-type="publisher-id">AOGS</journal-id><journal-title-group><journal-title>Acta Obstetricia et Gynecologica Scandinavica</journal-title></journal-title-group><issn pub-type="ppub">0001-6349</issn><issn pub-type="epub">1600-0412</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10577625</article-id><article-id pub-id-type="pmcid-ver">PMC10577625.1</article-id><article-id pub-id-type="pmcaid">10577625</article-id><article-id pub-id-type="pmcaiid">10577625</article-id><article-id pub-id-type="pmid">37491773</article-id><article-id pub-id-type="doi">10.1111/aogs.14642</article-id><article-id pub-id-type="publisher-id">AOGS14642</article-id><article-id pub-id-type="other">AOGS-23-0204.R1</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Original Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Pregnancy</subject></subj-group></article-categories><title-group><article-title>Pregestational maternal risk factors for preterm and term preeclampsia: A population&#8208;based cohort study</article-title><alt-title alt-title-type="left-running-head">Sande et al.</alt-title></title-group><contrib-group><contrib id="aogs14642-cr-0001" contrib-type="author" corresp="yes"><name name-style="western"><surname>Sande</surname><given-names initials="AK">Anne Kvie</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8927-2253</contrib-id><xref rid="aogs14642-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aogs14642-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>anne.kvie.sande@sus.no</email></address></contrib><contrib id="aogs14642-cr-0002" contrib-type="author"><name name-style="western"><surname>Dalen</surname><given-names initials="I">Ingvild</given-names></name><xref rid="aogs14642-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="aogs14642-cr-0003" contrib-type="author"><name name-style="western"><surname>Torkildsen</surname><given-names initials="EA">Erik Andreas</given-names></name><xref rid="aogs14642-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aogs14642-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="aogs14642-cr-0004" contrib-type="author"><name name-style="western"><surname>Sande</surname><given-names initials="RK">Ragnar Kvie</given-names></name><xref rid="aogs14642-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aogs14642-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="aogs14642-cr-0005" contrib-type="author"><name name-style="western"><surname>Morken</surname><given-names initials="NH">Nils&#8208;Halvdan</given-names></name><xref rid="aogs14642-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aogs14642-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib></contrib-group><aff id="aogs14642-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Obstetrics and Gynecology</named-content>
<institution>Stavanger University Hospital</institution>
<city>Stavanger</city>
<country country="NO">Norway</country>
</aff><aff id="aogs14642-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Clinical Science</named-content>
<institution>University of Bergen</institution>
<city>Bergen</city>
<country country="NO">Norway</country>
</aff><aff id="aogs14642-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Research, Section of Biostatistics</named-content>
<institution>Stavanger University Hospital</institution>
<city>Stavanger</city>
<country country="NO">Norway</country>
</aff><aff id="aogs14642-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Obstetrics and Gynecology</named-content>
<institution>Haukeland University Hospital</institution>
<city>Bergen</city>
<country country="NO">Norway</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Anne Kvie Sande, Helse Stavanger, HFPostboks 8100, Stavanger 4068, Norway.<break/>
Email: <email>anne.kvie.sande@sus.no</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>25</day><month>7</month><year>2023</year></pub-date><pub-date pub-type="collection"><month>11</month><year>2023</year></pub-date><volume>102</volume><issue seq="160">11</issue><issue-id pub-id-type="pmc-issue-id">447361</issue-id><issue-id pub-id-type="doi">10.1111/aogs.v102.11</issue-id><fpage>1549</fpage><lpage>1557</lpage><history><date date-type="rev-recd"><day>08</day><month>6</month><year>2023</year></date><date date-type="received"><day>20</day><month>3</month><year>2023</year></date><date date-type="accepted"><day>04</day><month>7</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>25</day><month>07</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>17</day><month>10</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-01-26 00:25:09.977"><day>26</day><month>01</month><year>2024</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2023 The Authors. <italic toggle="yes">Acta Obstetricia et Gynecologica Scandinavica</italic> published by John Wiley &amp; Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#8208;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="AOGS-102-1549.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:AOGS-102-1549.pdf"/><abstract><title>Abstract</title><sec id="aogs14642-sec-0001"><title>Introduction</title><p>Most studies on factors affecting the risk of preeclampsia have not separated preterm from term preeclampsia, and we still know little about whether the predisposing conditions have a differentiated effect on the risk of preterm and term preeclampsia. Our aim was to assess whether diabetes type 1 and 2, chronic kidney disease, asthma, epilepsy, rheumatoid arthritis and chronic hypertension were differentially associated with preterm and term preeclampsia.</p></sec><sec id="aogs14642-sec-0002"><title>Material and methods</title><p>This is a nationwide, population&#8208;based cohort study containing all births registered in the Medical Birth Registry of Norway from 1999 to 2016. Multinomial logistic regression analysis was used to estimate relative risk ratios (RRRs) with 95% confidence intervals (95% CIs), adjusting for maternal age, parity, multiple gestation and all other studied maternal risk factors.</p></sec><sec id="aogs14642-sec-0003"><title>Results</title><p>We registered 1&#8201;044&#8201;860 deliveries, of which 9533 (0.9%) women had preterm preeclampsia (&lt;37&#8201;weeks) and 26&#8201;504 (2.5%) women had term preeclampsia (&gt;37&#8201;weeks). Most of the assessed maternal risk factors were associated with increased risk for both preterm and term preeclampsia, with adjusted RRRs ranging from 1.2 to 10.5 (preterm vs no preeclampsia) and 0.9&#8211;5.7 (term vs no preeclampsia). Diabetes type 1 and 2 (RRR preterm vs term preeclampsia 2.89, 95% CI 2.46&#8211;3.39 and RRR 1.68, 95% CI 1.25&#8211;2.25, respectively), chronic kidney disease (RRR 1.55, 95% CI 1.11&#8211;2.17) and chronic hypertension (RRR 1.85, 95% CI 1.63&#8211;2.10) were more strongly associated with preterm than term preeclampsia in adjusted analyses. For asthma, epilepsy and rheumatoid arthritis, RRRs were closer to one and not significant when comparing risk of preterm and term preeclampsia. Main results were similar when using a diagnosis at &lt;34&#8201;weeks to define preterm preeclampsia.</p></sec><sec id="aogs14642-sec-0004"><title>Conclusions</title><p>Diabetes type 1 and 2, chronic kidney disease and chronic hypertension were more strongly associated with preterm than term preeclampsia.</p></sec></abstract><abstract abstract-type="graphical"><p>Preterm and term preeclampsia may differ in terms of pregestational risk factors. A population&#8208;based cohort study was carried out. Diabetes type 1 and 2, chronic kidney disease and chronic hypertension were more strongly associated with preterm than term preeclampsia.<boxed-text position="anchor" content-type="graphic" id="aogs14642-blkfxd-0001" orientation="portrait"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="AOGS-102-1549-g001.jpg"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="aogs14642-kwd-0001">epidemiology</kwd><kwd id="aogs14642-kwd-0002">risk factors</kwd><kwd id="aogs14642-kwd-0003">preterm preeclampsia</kwd><kwd id="aogs14642-kwd-0004">term preeclampsia</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>Stavanger University Hospital</funding-source></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>Universitetet i Bergen
</institution><institution-id institution-id-type="doi">10.13039/501100005036</institution-id></institution-wrap></funding-source><award-id>2019/26961&#8208;ELRI</award-id></award-group></funding-group><counts><fig-count count="5"/><table-count count="4"/><page-count count="9"/><word-count count="4935"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>November 2023</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.4 mode:remove_FC converted:16.10.2023</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="AOGS14642-cit-2001"><string-name name-style="western"><surname>Sande</surname><given-names>AK</given-names></string-name>, <string-name name-style="western"><surname>Dalen</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Torkildsen</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Sande</surname><given-names>RK</given-names></string-name>, <string-name name-style="western"><surname>Morken</surname><given-names>N&#8208;H</given-names></string-name>. <article-title>Pregestational maternal risk factors for preterm and term preeclampsia: A population&#8208;based cohort study</article-title>. <source>Acta Obstet Gynecol Scand</source>. <year>2023</year>;<volume>102</volume>:<fpage>1549</fpage>&#8208;<lpage>1557</lpage>. doi:<pub-id pub-id-type="doi">10.1111/aogs.14642</pub-id><pub-id pub-id-type="pmid">37491773</pub-id><pub-id pub-id-type="pmcid">PMC10577625</pub-id></mixed-citation>
</p></notes></front><body id="aogs14642-body-0001"><def-list list-content="abbreviations" id="aogs14642-lp-0001"><title>Abbreviations</title><def-item><term id="aogs14642-li-0001">BMI</term><def id="aogs14642-li-0002"><p>body mass index</p></def></def-item><def-item><term id="aogs14642-li-0003">CI</term><def id="aogs14642-li-0004"><p>confidence interval</p></def></def-item><def-item><term id="aogs14642-li-0005">MBRN</term><def id="aogs14642-li-0006"><p>The Medical Birth Registry of Norway</p></def></def-item><def-item><term id="aogs14642-li-0007">RRR</term><def id="aogs14642-li-0008"><p>relative risk ratio</p></def></def-item></def-list><p>
<boxed-text position="anchor" content-type="box" id="aogs14642-blkfxd-0002" orientation="portrait"><caption><title>Key message</title></caption><p>We have little knowledge about whether the well&#8208;known risk factors for preeclampsia have a differentiated association on preterm and term preeclampsia. Diabetes type 1 and 2, chronic kidney disease and chronic hypertension were more strongly associated with preterm than term preeclampsia.</p></boxed-text>
</p><sec id="aogs14642-sec-0007"><label>1</label><title>INTRODUCTION</title><p>Preeclampsia is a common cause of morbidity and mortality for both mothers and children worldwide<xref rid="aogs14642-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> and has been categorized into a preterm and a term entity.<xref rid="aogs14642-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> However, few population&#8208;based studies have assessed risk factors by the two entities separately.<xref rid="aogs14642-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> Preterm preeclampsia is considered more severe than term preeclampsia, as it is more strongly associated with fetal growth restriction and preterm delivery.<xref rid="aogs14642-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="aogs14642-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>
</p><p>No curative treatment is available for either preterm or term preeclampsia. It is shown that preterm preeclampsia can be effectively prevented by prophylactic use of acetylsalicylic acid from around gestational week 12.<xref rid="aogs14642-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> To offer prophylaxis to women most in need of this treatment, clinicians are dependent on identifying women at high risk of preterm preeclampsia early in pregnancy, preferably during the first trimester.<xref rid="aogs14642-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>
</p><p>Risk factors that only increase the risk of preterm preeclampsia and not term preeclampsia will easily be missed in studies not separating the two entities, as term preeclampsia is a much more prevalent pregnancy complication.<xref rid="aogs14642-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> Chronic hypertension, type 1 diabetes and maternal allergy are more strongly associated with preterm than term preeclampsia.<xref rid="aogs14642-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="aogs14642-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> However, it is not known whether this is also the case for other well&#8208;known predisposing conditions, such as type 2 diabetes, chronic kidney disease, asthma, epilepsy and rheumatoid arthritis. Some studies have found that chronic kidney disease and diabetes (not separating type 1 and 2) are risk factors for term preeclampsia.<xref rid="aogs14642-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="aogs14642-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> All the predisposing conditions are mainly immunological and have in previous studies been found to be associated with preeclampsia, although not separated by its preterm and term entity.<xref rid="aogs14642-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="aogs14642-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="aogs14642-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>, <xref rid="aogs14642-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="aogs14642-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="aogs14642-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> Evidence suggests that autoimmune mechanisms are also involved in epilepsy.<xref rid="aogs14642-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> In addition to increasing the risk for preeclampsia, asthma is associated with allergy, which is found to increase the risk for early&#8208;onset preeclampsia.<xref rid="aogs14642-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> There is also evidence that children born from preeclamptic mothers are at increased risk for developing asthma<xref rid="aogs14642-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> and allergic sensitization<xref rid="aogs14642-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> during childhood.</p><p>As it has been shown that early prediction and prevention of preeclampsia is possible, it is important to understand how different risk factors are associated with the two entities of preeclampsia. Use of maternal risk factors combined with mean arterial blood pressure, uterine arterial pulsatile index and maternal serum levels of placental growth factor and pregnancy&#8208;associated plasma protein&#8208;A, is better than screening based on maternal risk factors alone.<xref rid="aogs14642-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> Ultimately, assessing other well&#8208;known maternal risk factors by preterm and term preeclampsia may further improve detection rates when using such algorithms and may enable better prevention of preeclampsia using prophylactic acetylsalicylic acid.</p><p>The specific aim of this study was to assess whether diabetes type 1 and 2, chronic kidney disease, asthma, epilepsy, rheumatoid arthritis and chronic hypertension were more strongly associated with preterm than with term preeclampsia.</p></sec><sec sec-type="materials-and-methods" id="aogs14642-sec-0008"><label>2</label><title>MATERIAL AND METHODS</title><p>This is a nationwide population&#8208;based cohort study with prospectively collected data from The Medical Birth Registry of Norway (MBRN). All women giving birth in Norway from 1999 to 2016 were included. Deliveries of second born twins or higher order, missing gestational age, gestational age &lt;19+6&#8201;weeks, and gestational age &gt;44&#8201;weeks were excluded.</p><p>The MBRN is a compulsory national health register that holds information on pregestational conditions and prenatal&#8208;, peri&#8208;partum and post&#8208;natal care on all births in Norway. Information on pregestational conditions and previous pregnancies is registered at the first antenatal visit by the midwife or the general practitioner and written on the antenatal health card. The general practitioner usually keeps a record of the women's health since childhood. This form is used for follow&#8208;up throughout pregnancy and all noted information is sent electronically to the MBRN a few days postnatally by the attending midwife or obstetrician. The MBRN includes information on all pregnancies continuing past gestational week 12.</p><p>From the MBRN, we obtained the following pregestational conditions: Diabetes type 1 and 2, chronic kidney disease, asthma, epilepsy, rheumatoid arthritis and chronic hypertension. In addition, we obtained data on the occurrence of preeclampsia, early&#8208;onset preeclampsia, gestational age at delivery in days, date of delivery, maternal age, parity, occurrence of multiple pregnancies and pre&#8208;pregnancy body mass index (BMI).</p><p>In the MBRN, the infant is the counting unit. This means that all multiple pregnancies are registered as two or more deliveries. To make delivery the counting unit, second twins or higher orders were excluded.</p><p>The diagnostic criteria of preeclampsia have been changed in the past few years and it is now defined as new onset of hypertension after 20&#8201;weeks of pregnancy accompanied by one or more of the following conditions: proteinuria, renal insufficiency, liver involvement, neurological complications, hematological complications or uteroplacental dysfunction. Our dataset is from 1999 to 2016, and the participants were diagnosed with preeclampsia as it was then defined by the Norwegian Society of Gynecology and Obstetrics. This definition corresponded with the guidelines from the National Institute for Health and Care Excellence (NICE guidelines) at the time: proteinuria &#8805; +1 on a dipstick, &gt;0.3&#8201;g urine protein loss per 24&#8201;hours or a protein/creatinine ratio &gt;0.3 and repeated measurements of systolic blood pressure &#8805;140&#8201;mm&#8201;Hg and/or diastolic blood pressure &#8805;90&#8201;mm&#8201;Hg after 20&#8201;weeks&#8217; gestational age (ICD&#8208;10: O11, O14.0, O14.1, O14.2, O14.9).<xref rid="aogs14642-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> We defined preterm and term preeclampsia as preeclampsia resulting in delivery before and after gestational week 37 in our main analyses. This definition is the current definition recommended by the International Society of the Study of Hypertension in Pregnancy.<xref rid="aogs14642-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> We also did separate analyses where we defined early&#8208;onset and late&#8208;onset preeclampsia as preeclampsia diagnosed before and after gestational week 34, respectively. Registration of preeclampsia in the MBRN has been validated and found of high quality.<xref rid="aogs14642-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>
</p><sec id="aogs14642-sec-0009"><label>2.1</label><title>Statistical methods</title><p>Relative risk ratios (RRRs) with 95% confidence intervals (95% CI) for preterm preeclampsia and term preeclampsia vs no preeclampsia were estimated for each maternal risk factor using multinomial logistic regression. In addition, we compared relative risks of preterm and term preeclampsia. Cluster robust standard errors were used to account for repeated pregnancies in the same woman.</p><p>First, RRRs were estimated for each risk factor separately, adjusting for mother's age, parity and multiple gestation. In separate analyses, we additionally adjusted for diabetes type 1 and 2, chronic kidney disease, asthma, epilepsy, rheumatoid arthritis and chronic hypertension, as well as maternal age, parity and multiple gestation. In both analyses, maternal age was modeled non&#8208;linearly using restricted cubic splines with four knots, with number of knots decided by the Bayesian information criterion.</p><p>The registration of BMI in the MBRN started in 2006 and the proportion of deliveries where BMI was registered increased successively up until 2014, when the registration exceeded 70%. Thus, BMI was available in a subsample of registered deliveries. Separate analyses were performed for women with registered BMI, using the same strategy as described above, with additional adjustment for BMI modeled with restricted cubic splines with four knots.</p><p>Results from the fully adjusted model were illustrated in plots showing predicted proportions of preterm and term preeclampsia with 95% confidence intervals for each maternal risk factor. In addition, we present predicted proportions of preterm and term preeclampsia from unadjusted models given maternal age and BMI, with effects modeled using restricted cubic splines with four knots.</p><p>Data preparations were done in IBM SPSS Statistics for Windows (Version 26.0.0.1 Armonk, NY, USA, 2019) and analyses were done in STATA (Release 17. College Station, TX: Stata Corp LLC. Stata Corp, 2019) with functions mlogit, rc_spline, margins, marginsplot and mplotoffset.</p><p>We created a focus group of women with preeclampsia that assessed the background of our study and the proposed methods. Useful comments regarding risk factors for preeclampsia were suggested, and valuable insight into the use of patient and public involvement was presented through the discussions in our group. The group members agreed that the data protection seemed satisfactory in the proposed design of our study. The protocol was also assessed by the committee of user representatives at Stavanger University Hospital.</p></sec><sec id="aogs14642-sec-0010"><label>2.2</label><title>Ethics statement</title><p>Research using an anonymous health register data are exempt from consent requirements from the research ethics committees in Norway. The exemption was approved by the ethics committee of the Western Norwegian Regional Health Authorities on 7 April 2017 (2017/292/REK vest). The Data Protection Impact Assessment was approved by the data protection officer at Stavanger University Hospital and access to data was approved by the Norwegian Institute of Public Health.</p></sec></sec><sec sec-type="results" id="aogs14642-sec-0011"><label>3</label><title>RESULTS</title><p>The outline of the study population is presented in Figure&#160;<xref rid="aogs14642-fig-0001" ref-type="fig">1</xref>. The MBRN contained information on 1&#8201;075&#8201;637 born infants during 1999&#8211;2016. After exclusion of second born twins or higher order (<italic toggle="yes">n</italic>&#8201;=&#8201;19&#8201;035), missing gestational age (<italic toggle="yes">n</italic>&#8201;=&#8201;7089), gestational age &lt;19+6&#8201;weeks (<italic toggle="yes">n</italic>&#8201;=&#8201;4108) and gestational age &gt;44&#8201;weeks (<italic toggle="yes">n</italic>&#8201;=&#8201;545), we were left with 1&#8201;044&#8201;860 deliveries for the main analyses. Among these, there were 36&#8201;037 (3.4%) with preeclampsia &#8211; 9533 (0.9%) preterm and 26&#8201;504 (2.5%) term preeclampsia.</p><fig position="float" fig-type="FIGURE" id="aogs14642-fig-0001" orientation="portrait"><label>FIGURE 1</label><caption><p>Flow chart, Medical Birth Registry of Norway (MBRN), 1999&#8211;2016.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="AOGS-102-1549-g003.jpg"/></fig><p>Population characteristics are outlined in Table&#160;<xref rid="aogs14642-tbl-0001" ref-type="table">1</xref>. Maternal age were similar in the three groups: no preeclampsia, preterm and term preeclampsia. As expected, nulliparous and multiple pregnancies were more common in the preeclampsia groups than in the no preeclampsia group.</p><table-wrap position="float" id="aogs14642-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Population characteristics and pregestational maternal risk factors in 1&#8201;044&#8201;860 pregnancies by preterm, term and no preeclampsia, Medical Birth Registry of Norway, 1999&#8211;2016.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1"/><th style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1" colspan="1">No preeclampsia</th><th style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1" colspan="1">Preterm preeclampsia</th><th style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1" colspan="1">Term preeclampsia</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">n</italic> (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">n</italic> (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">n</italic> (%)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Total</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1&#8201;008&#8201;823 (96.6)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">9533 (0.9)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">26&#8201;504 (2.5)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Maternal age, mean (SD)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">29.7 (5.1)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">29.8 (5.6)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">29.2 (5.5)</td></tr><tr><td align="left" colspan="4" valign="top" rowspan="1">Parity</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Nulliparous (435&#8201;501)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">413&#8201;670 (41.0)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">5745 (60.3)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">16&#8201;086 (60.7)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Multiparous (609 359)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">595&#8201;153 (59.0)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">3788 (39.7)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">10&#8201;418 (39.3)</td></tr><tr><td align="left" colspan="4" valign="top" rowspan="1">Multiple pregnancy</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Singletons (1&#8201;026&#8201;437)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">992&#8201;517 (98.4)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">8236 (86.4)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">25&#8201;684 (96.9)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Multiples (18&#8201;423)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">16&#8201;306 (1.6)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1297 (13.6)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">820 (3.1)</td></tr><tr><td align="left" colspan="4" valign="top" rowspan="1">Predisposing factors</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Type 1 diabetes (4722)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">4041 (0.4)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">346 (3.6)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">335 (1.3)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Type 2 diabetes (2430)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">2204 (0.2)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">93 (1.0)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">133 (0.5)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Kidney disease (3080)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">2928 (0.3)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">57 (0.6)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">95 (0.4)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Asthma (46 555)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">44&#8201;501 (4.4)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">514 (5.4)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1540 (5.8)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Epilepsy (7235)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">6887 (0.7)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">104 (1.1)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">244 (0.9)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Rheumatoid arthritis (3550)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">3413 (0.3)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">48 (0.5)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">89 (0.3)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hypertension (5885)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">4726 (0.5)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">480 (5.1)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">679 (2.6)</td></tr></tbody></table></table-wrap><p>Main analyses are presented in Table&#160;<xref rid="aogs14642-tbl-0002" ref-type="table">2</xref> and illustrated in Figure&#160;<xref rid="aogs14642-fig-0002" ref-type="fig">2</xref>. When adjusting for all other maternal risk factors in addition to age, parity and multiple births, diabetes type 1 (RRR 2.89, 95% CI 2.46&#8211;3.39), diabetes type 2 (RRR 1.68, 95% CI 1.25&#8211;2.25), chronic kidney disease (RRR 1.55, 95% CI 1.11&#8211;2.17) and chronic hypertension (RRR 1.85, 95% CI 1.63&#8211;2.10) were more strongly associated with preterm preeclampsia than with term preeclampsia. The adjusted RRRs for asthma, epilepsy and rheumatoid arthritis were 0.93 (95% CI 0.84&#8211;1.03), 1.14 (95% CI 0.90&#8211;1.45) and 1.33 (95% CI 0.93&#8211;1.91), respectively.</p><table-wrap position="float" id="aogs14642-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Adjusted relative risk ratios (RRRs) with 95% confidence intervals (95% CIs) for preterm preeclampsia vs no preeclampsia (no PE), term preeclampsia vs no PE and preterm vs term preeclampsia by maternal risk factors. Estimates were obtained by multinomial logistic regression in 1&#8201;044&#8201;860 deliveries, Medical Birth Registry of Norway, 1999&#8211;2016.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1"/><th colspan="3" style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1">Adjusted<xref rid="aogs14642-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref> RRRs (95% CIs)</th><th colspan="3" style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1">Adjusted<xref rid="aogs14642-note-0003" ref-type="table-fn">
<sup>b</sup>
</xref> RRRs (95% CIs)</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Maternal risk factors</th><th align="left" valign="bottom" rowspan="1" colspan="1">Preterm vs no PE</th><th align="left" valign="bottom" rowspan="1" colspan="1">Term vs no PE</th><th align="left" valign="bottom" rowspan="1" colspan="1">Preterm vs term</th><th align="left" valign="bottom" rowspan="1" colspan="1">Preterm vs no PE</th><th align="left" valign="bottom" rowspan="1" colspan="1">Term vs no PE</th><th align="left" valign="bottom" rowspan="1" colspan="1">Preterm vs term</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Diabetes type 1</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">9.70 (8.55&#8211;11.00)</td><td align="left" valign="top" rowspan="1" colspan="1">3.21 (2.86&#8211;3.62)</td><td align="left" valign="top" rowspan="1" colspan="1">3.02 (2.57&#8211;3.54)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">8.92 (7.83&#8211;10.15)</td><td align="left" valign="top" rowspan="1" colspan="1">3.09 (2.74&#8211;3.48)</td><td align="left" valign="top" rowspan="1" colspan="1">2.89 (2.46&#8211;3.39)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Diabetes type 2</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">4.64 (3.65&#8211;5.90)</td><td align="left" valign="top" rowspan="1" colspan="1">2.45 (2.05&#8211;2.93)</td><td align="left" valign="top" rowspan="1" colspan="1">1.89 (1.42&#8211;2.53)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">3.53 (2.73&#8211;4.58)</td><td align="left" valign="top" rowspan="1" colspan="1">2.10 (1.75&#8211;2.53)</td><td align="left" valign="top" rowspan="1" colspan="1">1.68 (1.25&#8211;2.25)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chronic kidney disease</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">2.01 (1.54&#8211;2.64)</td><td align="left" valign="top" rowspan="1" colspan="1">1.18 (0.96&#8211;1.46)</td><td align="left" valign="top" rowspan="1" colspan="1">1.70 (1.22&#8211;2.38)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1.74 (1.31&#8211;2.29)</td><td align="left" valign="top" rowspan="1" colspan="1">1.12 (0.90&#8211;1.38)</td><td align="left" valign="top" rowspan="1" colspan="1">1.55 (1.11&#8211;2.17)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Asthma</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1.22 (1.11&#8211;1.34)</td><td align="left" valign="top" rowspan="1" colspan="1">1.30 (1.23&#8211;1.38)</td><td align="left" valign="top" rowspan="1" colspan="1">0.94 (0.84&#8211;1.04)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1.20 (1.09&#8211;1.31)</td><td align="left" valign="top" rowspan="1" colspan="1">1.29 (1.22&#8211;1.36)</td><td align="left" valign="top" rowspan="1" colspan="1">0.93 (0.84&#8211;1.03)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Epilepsy</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1.60 (1.30&#8211;1.96)</td><td align="left" valign="top" rowspan="1" colspan="1">1.33 (1.16&#8211;1.53)</td><td align="left" valign="top" rowspan="1" colspan="1">1.20 (0.94&#8211;1.52)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1.44 (1.17&#8211;1.77)</td><td align="left" valign="top" rowspan="1" colspan="1">1.26 (1.10&#8211;1.45)</td><td align="left" valign="top" rowspan="1" colspan="1">1.14 (0.90&#8211;1.45)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rheumatoid arthritis</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1.39 (1.03&#8211;1.86)</td><td align="left" valign="top" rowspan="1" colspan="1">0.97 (0.79&#8211;1.20)</td><td align="left" valign="top" rowspan="1" colspan="1">1.42 (1.00&#8211;2.03)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1.23 (0.91&#8211;1.66)</td><td align="left" valign="top" rowspan="1" colspan="1">0.92 (0.74&#8211;1.14)</td><td align="left" valign="top" rowspan="1" colspan="1">1.33 (0.93&#8211;1.91)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chronic hypertension</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">11.65 (10.50&#8211;12.93)</td><td align="left" valign="top" rowspan="1" colspan="1">5.89 (5.40&#8211;6.42)</td><td align="left" valign="top" rowspan="1" colspan="1">1.98 (1.75&#8211;2.24)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">10.46 (9.38&#8211;11.66)</td><td align="left" valign="top" rowspan="1" colspan="1">5.65 (5.18&#8211;6.17)</td><td align="left" valign="top" rowspan="1" colspan="1">1.85 (1.63&#8211;2.10)</td></tr></tbody></table><table-wrap-foot id="aogs14642-ntgp-0001"><fn id="aogs14642-note-0001"><p>Abbreviation: PE, preeclampsia.</p></fn><fn id="aogs14642-note-0002"><label>
<sup>a</sup>
</label><p>Adjusted for age, parity and multiple births.</p></fn><fn id="aogs14642-note-0003"><label>
<sup>b</sup>
</label><p>Adjusted for maternal age, parity, multiple births and all other risk factors.</p></fn></table-wrap-foot></table-wrap><fig position="float" fig-type="FIGURE" id="aogs14642-fig-0002" orientation="portrait"><label>FIGURE 2</label><caption><p>Predicted proportions (%) with 95% confidence intervals of preterm (dark gray) and term (light gray) preeclampsia according to presence of maternal risk factors: (A) diabetes, (B) chronic kidney disease, (C) asthma, (D) epilepsy, (E) rheumatoid arthritis and (F) chronic hypertension. Predicted proportions are based on the fully adjusted model presented in Table&#160;<xref rid="aogs14642-tbl-0002" ref-type="table">2</xref>, and given presence of no other risk factors, age 30&#8201;years, multiparity and singleton pregnancy.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="AOGS-102-1549-g004.jpg"/></fig><p>Population characteristics in the subgroup of 310&#8201;399 women with registered pre&#8208;pregnancy BMI are equivalent to the characteristics of the total study population and are presented in Table&#160;<xref rid="aogs14642-tbl-0003" ref-type="table">3</xref>.</p><table-wrap position="float" id="aogs14642-tbl-0003" content-type="TABLE" orientation="portrait"><label>TABLE 3</label><caption><p>Population characteristics and pregestational maternal risk factors in 310&#8201;399 pregnancies with registered maternal BMI by preterm, term and no preeclampsia, Medical Birth Registry of Norway, 2006&#8211;2016.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="2" style="border-bottom:solid 1px #000000" valign="bottom" colspan="1"/><th style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1" colspan="1">No preeclampsia</th><th style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1" colspan="1">Preterm preeclampsia</th><th style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1" colspan="1">Term preeclampsia</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">n</italic> (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">&lt;37 (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">&gt;37 (%)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Total (310&#8201;399)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">300&#8201;867 (96.9)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">2433 (0.8)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">7099 (2.3)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Maternal age, mean (SD)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">29.9 (5.1)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">30.3 (5.9)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">29.4 (5.6)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BMI, mean (SD)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">24.3 (4.7)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">26.1 (5.5)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">26.5 (5.8)</td></tr><tr><td align="left" colspan="4" valign="top" rowspan="1">Parity</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Nulliparous (134&#8201;718)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">128&#8201;820 (42.8)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1487 (61.1)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">4411 (62.1)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Multiparous (175&#8201;681)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">172&#8201;047 (57.2)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">946 (38.9)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">2688 (37.9)</td></tr><tr><td align="left" colspan="4" valign="top" rowspan="1">Multiple pregnancy</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Singletons (305&#8201;216)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">296&#8201;267 (98.5)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">2064 (84.8)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">6885 (97.0)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Multiples (5183)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">4600 (1.5)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">369 (15.2)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">214 (3.0)</td></tr><tr><td align="left" colspan="4" valign="top" rowspan="1">Predisposing factors</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Type 1 diabetes (1316)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1141 (0.4)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">87 (3.6)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">88 (1.2)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Type 2 diabetes (750)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">677 (0.2)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">28 (1.2)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">45 (0.6)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Kidney disease (1261)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1220 (0.4)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">14 (0.6)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">27 (0.4)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Asthma (16 125)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">15&#8201;532 (5.2)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">152 (6.2)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">441 (6.2)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Epilepsy (1946)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1858 (0.6)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">28 (1.2)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">60 (0.8)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Rheumatoid arthritis (1429)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1387 (0.5)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">12 (0.5)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">30 (0.4)</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hypertension (1921)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1589 (0.5)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">129 (5.3)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">203 (2.9)</td></tr></tbody></table></table-wrap><p>In Table&#160;<xref rid="aogs14642-tbl-0004" ref-type="table">4</xref> we present RRRs adjusted for the same variables as in main analyses (Table&#160;<xref rid="aogs14642-tbl-0002" ref-type="table">2</xref>), plus BMI, for the subgroup for which we had access to BMI. Diabetes type 1 (RRR 2.95, 2.16&#8211;4.02) and type 2 (RRR 1.74, 95% CI 1.05&#8211;2.88), and chronic hypertension (RRR 1.87, 95% CI 1.46&#8211;2.40) were still more strongly associated with preterm than with term preeclampsia, with point estimates similar to estimates from main analyses. For chronic kidney disease, the adjusted RRR was slightly lower than in the main analyses, and not significant (RRR 1.38, 95% CI 0.72&#8211;2.66). After adjusting for BMI, the association for diabetes type 2 on term preeclampsia is not as strong as in the main analysis (RRR 1.63, 95% CI 1.19&#8211;2.24), indicating the confounding effect of BMI on this association.</p><table-wrap position="float" id="aogs14642-tbl-0004" content-type="TABLE" orientation="portrait"><label>TABLE 4</label><caption><p>Adjusted relative risk ratios (RRRs) with 95% confidence intervals (95% CIs) for preterm preeclampsia vs no preeclampsia (no PE), term preeclampsia vs no PE and preterm vs term preeclampsia by maternal risk factors in 310&#8201;399 births with information on body mass index. Estimates were obtained by multinomial logistic regression, Medical Birth Registry of Norway, 2006&#8211;2016.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1"/><th align="left" colspan="3" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Adjusted<xref rid="aogs14642-note-0005" ref-type="table-fn">
<sup>a</sup>
</xref> RRRs (95% CIs)</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Maternal risk factors</th><th align="left" valign="bottom" rowspan="1" colspan="1">Preterm vs no PE</th><th align="left" valign="bottom" rowspan="1" colspan="1">Term vs no PE</th><th align="left" valign="bottom" rowspan="1" colspan="1">Preterm vs term</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Diabetes type 1</td><td align="left" valign="top" rowspan="1" colspan="1">8.32 (6.50&#8211;10.64)</td><td align="left" valign="top" rowspan="1" colspan="1">2.82 (2.24&#8211;3.55)</td><td align="left" valign="top" rowspan="1" colspan="1">2.95 (2.16&#8211;4.02)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Diabetes type 2</td><td align="left" valign="top" rowspan="1" colspan="1">2.84 (1.83&#8211;4.41)</td><td align="left" valign="top" rowspan="1" colspan="1">1.63 (1.19&#8211;2.24)</td><td align="left" valign="top" rowspan="1" colspan="1">1.74 (1.05&#8211;2.88)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chronic kidney disease</td><td align="left" valign="top" rowspan="1" colspan="1">1.26 (0.73&#8211;2.18)</td><td align="left" valign="top" rowspan="1" colspan="1">0.91 (0.62&#8211;1.35)</td><td align="left" valign="top" rowspan="1" colspan="1">1.38 (0.72&#8211;2.66)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Asthma</td><td align="left" valign="top" rowspan="1" colspan="1">1.08 (0.91&#8211;1.28)</td><td align="left" valign="top" rowspan="1" colspan="1">1.03 (0.93&#8211;1.14)</td><td align="left" valign="top" rowspan="1" colspan="1">1.05 (0.87&#8211;1.27)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Epilepsy</td><td align="left" valign="top" rowspan="1" colspan="1">1.83 (1.21&#8211;2.75)</td><td align="left" valign="top" rowspan="1" colspan="1">1.29 (0.98&#8211;1.68)</td><td align="left" valign="top" rowspan="1" colspan="1">1.42 (0.88&#8211;2.30)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rheumatoid arthritis</td><td align="left" valign="top" rowspan="1" colspan="1">0.80 (0.44&#8211;1.47)</td><td align="left" valign="top" rowspan="1" colspan="1">0.83 (0.58&#8211;1.20)</td><td align="left" valign="top" rowspan="1" colspan="1">0.97 (0.48&#8211;1.93)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chronic hypertension</td><td align="left" valign="top" rowspan="1" colspan="1">7.35 (5.94&#8211;9.09)</td><td align="left" valign="top" rowspan="1" colspan="1">3.93 (3.33&#8211;4.63)</td><td align="left" valign="top" rowspan="1" colspan="1">1.87 (1.46&#8211;2.40)</td></tr></tbody></table><table-wrap-foot id="aogs14642-ntgp-0002"><fn id="aogs14642-note-0004"><p>Abbreviation: PE, preeclampsia.</p></fn><fn id="aogs14642-note-0005"><label>
<sup>a</sup>
</label><p>Adjusted for maternal age, parity, multiple births, all other risk factors and body mass index.</p></fn></table-wrap-foot></table-wrap><p>The unadjusted effects of maternal age and BMI on risk of preterm and term preeclampsia are presented in prediction plots (Figures&#160;<xref rid="aogs14642-fig-0003" ref-type="fig">3</xref> and <xref rid="aogs14642-fig-0004" ref-type="fig">4</xref>). Maternal age has a classical U&#8208;shaped curve with predicted proportions at the lowest point when the women are in their early thirties. For BMI there is an abrupt increase in predicted proportion around a BMI of 23.</p><fig position="float" fig-type="FIGURE" id="aogs14642-fig-0003" orientation="portrait"><label>FIGURE 3</label><caption><p>Predicted proportions (%) with 95% confidence intervals of preterm (dark gray) and term (light gray) preeclampsia according to maternal age using restricted cubic splines with four knots. Medical Birth Registry of Norway, 1999&#8211;2016, based on 1&#8201;044&#8201;860 pregnancies.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-7" orientation="portrait" xlink:href="AOGS-102-1549-g005.jpg"/></fig><fig position="float" fig-type="FIGURE" id="aogs14642-fig-0004" orientation="portrait"><label>FIGURE 4</label><caption><p>Predicted proportions (%) with 95% confidence intervals of preterm (dark gray) and term (light gray) preeclampsia according to maternal body mass index (BMI) using restricted cubic splines with four knots. Medical Birth Registry of Norway, 2006&#8211;2016, based on 310&#8201;399 pregnancies with available data on BMI.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-9" orientation="portrait" xlink:href="AOGS-102-1549-g002.jpg"/></fig><p>When using the definition for the two entities registered in MBRN, early&#8208;onset and late&#8208;onset preeclampsia as diagnosed before or after 34&#8201;weeks of gestation, respectively, we found that diabetes type 1, diabetes type 2, chronic kidney disease, chronic hypertension and rheumatoid arthritis were more strongly associated with early&#8208;onset preeclampsia than with late&#8208;onset preeclampsia (Tables&#160;<xref rid="aogs14642-supitem-0001" ref-type="supplementary-material">S1</xref> and <xref rid="aogs14642-supitem-0001" ref-type="supplementary-material">S2</xref>).</p><p>Crude RRRs for both definitions (preterm/term and early&#8208;onset/late&#8208;onset) of preeclampsia were similar to the main analysis for diabetes type 1, diabetes type 2, chronic kidney disease, chronic hypertension and rheumatoid arthritis, but the associations were a bit stronger (Table&#160;<xref rid="aogs14642-supitem-0001" ref-type="supplementary-material">S3</xref>).</p></sec><sec sec-type="discussion" id="aogs14642-sec-0012"><label>4</label><title>DISCUSSION</title><p>Diabetes type 1 and 2, chronic kidney disease and chronic hypertension were more strongly associated with preterm than with term preeclampsia. The first three are all immunological diseases, and we believe that our findings indicate that preeclampsia is a disease with a large immunological component. The risk of preterm preeclampsia has its lowest point when the woman is in her early 30s, possibly when she has her second child and is benefitting from being both multipara and relatively young.</p><p>The pathophysiology of preeclampsia is still incompletely understood. Insufficient remodeling of the spiral arteries are thought to be important, in addition to different immunological factors that are believed to play a significant role in development of preeclampsia.<xref rid="aogs14642-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> Diabetes type 1 and 2, chronic kidney disease and rheumatoid arthritis are all immunological diseases, and a common feature is their increased levels of pro&#8208;inflammatory interleukin&#8208;6 in affected individuals.<xref rid="aogs14642-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> Elevated levels of interleukin&#8208;6 are also seen in people with high BMI<xref rid="aogs14642-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> and might explain the increase in predicted proportions when BMI exceeds 23. Levels of interleukin&#8208;6 in normal pregnancies decrease from the first and throughout most of the second trimester, when levels slowly increase again through the third trimester. Interleukin&#8208;6 levels also continue to rise a few months postpartum.<xref rid="aogs14642-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> Previous studies show elevated levels of interleukin&#8208;6 in women with preeclampsia.<xref rid="aogs14642-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>, <xref rid="aogs14642-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> This indicates that preeclampsia is a condition with a large immunological component. Additional knowledge about pathogenesis, maternal pregestational risk factors and their different association with preterm and term preeclampsia may help in developing more individualized follow&#8208;up throughout pregnancy. This may ultimately pave the way for new and better treatments for women at highest risk.</p><p>Early screening of preeclampsia is most useful when maternal characteristics and medical history is added in an algorithm based on multivariate regression analyses. If all pregestational risk factors are given the same weight in risk calculations, more than half of the pregnant population is at high risk and would thus need closer follow&#8208;up during pregnancy.<xref rid="aogs14642-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> When constructing such algorithms, one must quantify the association between the different risk factors and preterm and term preeclampsia. This way, development of preterm and term preeclampsia can be more accurately predicted. Previous studies have shown that by using algorithms containing maternal factors, uterine artery pulsatile index, mean arterial blood pressure and biophysical markers such as pregnancy&#8208;associated plasma protein&#8208;A, placental growth factor, Inhibin&#8208;A, Activin&#8208;A and s&#8208;Endoglin, one can predict 91% of preterm preeclampsia and 61% of term preeclampsia. Both assessments have a false&#8208;positive rate of 5%.<xref rid="aogs14642-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> By estimating risk factors association with both preterm and term preeclampsia, we believe that our study contributes to this field and can help improve the accuracy of existing algorithms.</p><p>A noteworthy and interesting finding from our study, particularly related to well&#8208;known confounders for preeclampsia, is that preeclampsia increases with increasing maternal age in parallel for both its preterm and term entity, whereas this was not the case for BMI (Figures&#160;<xref rid="aogs14642-fig-0003" ref-type="fig">3</xref> and <xref rid="aogs14642-fig-0004" ref-type="fig">4</xref>). Increasing BMI is particularly associated with increasing risk of term preeclampsia. This has earlier been found when using 34&#8201;weeks&#8217; gestation as a cut&#8208;off for early and late onset preeclampsia.<xref rid="aogs14642-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>
</p><p>Our study has several strengths. Data were collected from a large national database, with comprehensive clinical data. Information on pregestational conditions was gathered in an interview during the first trimester by the responsible midwife or general practitioner, and additional information was prospectively added throughout pregnancy. All information is noted on the antenatal health card for pregnant women in Norway, and the form is brought to the delivery ward when the woman is in labor. After delivery, all collected information on pregestational and gestational conditions together with information regarding delivery and the postpartum period is sent electronically to the MBRN by the attending midwife.</p><p>With a large sample size, we were able to identify associations between preterm preeclampsia, a rare condition in itself, and conditions with low prevalence in the obstetric population, such as chronic kidney disease.<xref rid="aogs14642-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>
</p><p>The main limitation of our study is that the data are self&#8208;reported, so recall bias might be an issue. The information on pregestational conditions is obtained by a midwife or the general practitioner. Although we do not know whether the information on pregestational conditions is the woman's own interpretation of her condition, we do know that most general practitioners in Norway have a thorough knowledge of their patient's medical history gathered from the general practitioner's health record system. Also, self&#8208;reported data in pregnancy are considered reasonably valid,<xref rid="aogs14642-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> and the incidence of pregestational maternal risk factors in our study is in line with previous findings,<xref rid="aogs14642-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="aogs14642-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>, <xref rid="aogs14642-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref>, <xref rid="aogs14642-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref> indicating that our database is most likely valid.<xref rid="aogs14642-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> The precise gestational age at the time of diagnosis is not specifically recorded in the MBRN. Within the investigated time frame, preeclampsia is defined as either early&#8208;onset or late&#8208;onset preeclampsia based on whether the diagnosis was set before or after gestational week 34. This is the available variable provided for our analysis through the MBRN. However, since we had access to information on ultrasound&#8208;based due dates and dates of birth, we could create the variables &#8220;Preeclampsia resulting in delivery before or after gestational week 37&#8221;. In addition, BMI was registered in the MBRN only from 2006, which limited our ability to account for its possibly confounding effect in main analyses.</p></sec><sec sec-type="conclusions" id="aogs14642-sec-0013"><label>5</label><title>CONCLUSION</title><p>All the assessed risk factors were associated with preeclampsia. Diabetes type 1 and 2, chronic kidney disease and chronic hypertension were more strongly associated with preterm than term preeclampsia. Asthma, epilepsy and rheumatoid arthritis were not associated differently with preterm vs term preeclampsia. We believe our study may be a valuable contribution for creating better accuracy in existing algorithms used for early prediction of preeclampsia.</p></sec><sec id="aogs14642-sec-0014"><title>AUTHOR CONTRIBUTIONS</title><p>AKS, EAT, RKS, and NHM have all participated in the conception of the idea, writing of the protocol, application for funding and application for ethical approval. ID conducted the statistical analysis with support from AKS, RKS and NHM. AKS, ID, EAT, RKS and NHM have all participated in writing the paper. All authors have approved the final version.</p></sec><sec id="aogs14642-sec-0015"><title>FUNDING INFORMATION</title><p>The study was funded by Stavanger University Hospital and the University of Bergen, Norway. Grant number 2019/26961&#8208;ELRI.</p></sec><sec sec-type="COI-statement" id="aogs14642-sec-0016"><title>CONFLICT OF INTEREST STATEMENT</title><p>AKS, ID and EAT have no conflicts of interest to declare. RKS is at the board of the Nordic Federation of Societies of Obstetrics and Gynecology. Other than this, he has no conflicts of interest to declare. NHM is a former associate editor of AOGS. Other than this, he has no conflicts of interest to declare.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="aogs14642-supitem-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>
Table S1.
</p><p>
Table S2.
</p><p>
Table S3.
</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="AOGS-102-1549-s001.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="aogs14642-sec-0017"><title>ACKNOWLEDGMENTS</title><p>The Medical Birth Registry of Norway has provided the data set for the analyses. The authors would like to thank Arild Osen in particular for his help in this.</p></ack><ref-list content-type="cited-references" id="aogs14642-bibl-0001"><title>REFERENCES</title><ref id="aogs14642-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="aogs14642-cit-0001"><string-name name-style="western"><surname>Say</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Chou</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Gemmill</surname><given-names>A</given-names></string-name>, et al. <article-title>Global causes of maternal death: a WHO systematic analysis</article-title>. <source>Lancet Glob Health</source>. <year>2014</year>;<volume>2</volume>:<fpage>e323</fpage>&#8208;<lpage>e333</lpage>.<pub-id pub-id-type="pmid">25103301</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2214-109X(14)70227-X</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="aogs14642-cit-0002"><string-name name-style="western"><surname>Ness</surname><given-names>RB</given-names></string-name>, <string-name name-style="western"><surname>Roberts</surname><given-names>JM</given-names></string-name>. <article-title>Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications</article-title>. <source>Am J Obstet Gynecol</source>. <year>1996</year>;<volume>175</volume>:<fpage>1365</fpage>&#8208;<lpage>1370</lpage>.<pub-id pub-id-type="pmid">8942516</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0002-9378(96)70056-x</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="aogs14642-cit-0003"><string-name name-style="western"><surname>Poon</surname><given-names>LC</given-names></string-name>, <string-name name-style="western"><surname>Nicolaides</surname><given-names>KH</given-names></string-name>. <article-title>Early prediction of preeclampsia</article-title>. <source>Obstet Gynecol Int</source>. <year>2014</year>;<volume>2014</volume>:<elocation-id>297397</elocation-id>.<pub-id pub-id-type="pmid">25136369</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2014/297397</pub-id><pub-id pub-id-type="pmcid">PMC4127237</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="aogs14642-cit-0004"><string-name name-style="western"><surname>Long</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>Abell</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Beischer</surname><given-names>NA</given-names></string-name>. <article-title>Fetal growth retardation and pre&#8208;eclampsia</article-title>. <source>Br J Obstet Gynaecol</source>. <year>1980</year>;<volume>87</volume>:<fpage>13</fpage>&#8208;<lpage>18</lpage>.<pub-id pub-id-type="pmid">7362784</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1471-0528.1980.tb04419.x</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="aogs14642-cit-0005"><string-name name-style="western"><surname>Rasmussen</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Irgens</surname><given-names>LM</given-names></string-name>. <article-title>Fetal growth and body proportion in preeclampsia</article-title>. <source>Obstet Gynecol</source>. <year>2003</year>;<volume>101</volume>:<fpage>575</fpage>&#8208;<lpage>583</lpage>.<pub-id pub-id-type="pmid">12636965</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0029-7844(02)03071-5</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="aogs14642-cit-0006"><string-name name-style="western"><surname>Rolnik</surname><given-names>DL</given-names></string-name>, <string-name name-style="western"><surname>Wright</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Poon</surname><given-names>LC</given-names></string-name>, et al. <article-title>Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia</article-title>. <source>N Engl J Med</source>. <year>2017</year>;<volume>377</volume>:<fpage>613</fpage>&#8208;<lpage>622</lpage>.<pub-id pub-id-type="pmid">28657417</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa1704559</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="aogs14642-cit-0007"><string-name name-style="western"><surname>Sande</surname><given-names>AK</given-names></string-name>, <string-name name-style="western"><surname>Torkildsen</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Sande</surname><given-names>RK</given-names></string-name>, <string-name name-style="western"><surname>Morken</surname><given-names>NH</given-names></string-name>. <article-title>Maternal allergy as an isolated risk factor for early&#8208;onset preeclampsia: an epidemiological study</article-title>. <source>J Reprod Immunol</source>. <year>2018</year>;<volume>127</volume>:<fpage>43</fpage>&#8208;<lpage>47</lpage>.<pub-id pub-id-type="pmid">29758487</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jri.2018.04.004</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="aogs14642-cit-0008"><string-name name-style="western"><surname>Lisonkova</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Joseph</surname><given-names>KS</given-names></string-name>. <article-title>Incidence of preeclampsia: risk factors and outcomes associated with early&#8208; versus late&#8208;onset disease</article-title>. <source>Am J Obstet Gynecol</source>. <year>2013</year>;<volume>209</volume>(<issue>544</issue>):<fpage>e1</fpage>&#8208;<lpage>e12</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajog.2013.08.019</pub-id><pub-id pub-id-type="pmid">23973398</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="aogs14642-cit-0009"><string-name name-style="western"><surname>Robillard</surname><given-names>P&#8208;Y</given-names></string-name>, <string-name name-style="western"><surname>Boukerrou</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Dekker</surname><given-names>G</given-names></string-name>, et al. <article-title>Risk factors for early and late onset preeclampsia in Reunion Island: multivariate analysis of singleton and twin pregnancies. A 20&#8208;year population&#8208;based cohort of 2120 preeclampsia cases</article-title>. <source>Reprod Med</source>. <year>2021</year>;<volume>2</volume>:<fpage>131</fpage>&#8208;<lpage>143</lpage>.</mixed-citation></ref><ref id="aogs14642-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="aogs14642-cit-0010"><string-name name-style="western"><surname>Ornoy</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Becker</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Weinstein&#8208;Fudim</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Ergaz</surname><given-names>Z</given-names></string-name>. <article-title>Diabetes during pregnancy: a maternal disease complicating the course of pregnancy with Long&#8208;term deleterious effects on the offspring. A clinical review</article-title>. <source>Int J Mol Sci</source>. <year>2021</year>;<volume>22</volume>:<fpage>2965</fpage>.<pub-id pub-id-type="pmid">33803995</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms22062965</pub-id><pub-id pub-id-type="pmcid">PMC7999044</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="aogs14642-cit-0011"><string-name name-style="western"><surname>Williams</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Davison</surname><given-names>J</given-names></string-name>. <article-title>Chronic kidney disease in pregnancy</article-title>. <source>BMJ</source>. <year>2008</year>;<volume>336</volume>:<fpage>211</fpage>&#8208;<lpage>215</lpage>.<pub-id pub-id-type="pmid">18219043</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.39406.652986.BE</pub-id><pub-id pub-id-type="pmcid">PMC2213870</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="aogs14642-cit-0012"><string-name name-style="western"><surname>Bonham</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Patterson</surname><given-names>KC</given-names></string-name>, <string-name name-style="western"><surname>Strek</surname><given-names>ME</given-names></string-name>. <article-title>Asthma outcomes and management during pregnancy</article-title>. <source>Chest</source>. <year>2018</year>;<volume>153</volume>:<fpage>515</fpage>&#8208;<lpage>527</lpage>.<pub-id pub-id-type="pmid">28867295</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chest.2017.08.029</pub-id><pub-id pub-id-type="pmcid">PMC5815874</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="aogs14642-cit-0013"><string-name name-style="western"><surname>Borthen</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Gilhus</surname><given-names>NE</given-names></string-name>. <article-title>Pregnancy complications in patients with epilepsy</article-title>. <source>Curr Opinion Obstet Gynecol</source>. <year>2012</year>;<volume>24</volume>:<fpage>78</fpage>&#8208;<lpage>83</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/GCO.0b013e32834feb6a</pub-id><pub-id pub-id-type="pmid">22327733</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="aogs14642-cit-0014"><string-name name-style="western"><surname>Lin</surname><given-names>HC</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>SF</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>HC</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>YH</given-names></string-name>. <article-title>Increased risk of adverse pregnancy outcomes in women with rheumatoid arthritis: a nationwide population&#8208;based study</article-title>. <source>Ann Rheum Dis</source>. <year>2010</year>;<volume>69</volume>:<fpage>715</fpage>&#8208;<lpage>717</lpage>.<pub-id pub-id-type="pmid">19406733</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/ard.2008.105262</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="aogs14642-cit-0015"><string-name name-style="western"><surname>Sibai</surname><given-names>BM</given-names></string-name>, <string-name name-style="western"><surname>Lindheimer</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hauth</surname><given-names>J</given-names></string-name>, et al. <article-title>Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development network of maternal&#8208;fetal medicine units</article-title>. <source>N Engl J Med</source>. <year>1998</year>;<volume>339</volume>:<fpage>667</fpage>&#8208;<lpage>671</lpage>.<pub-id pub-id-type="pmid">9725924</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJM199809033391004</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="aogs14642-cit-0016"><string-name name-style="western"><surname>Cojocaru</surname><given-names>IM</given-names></string-name>, <string-name name-style="western"><surname>Cojocaru</surname><given-names>M</given-names></string-name>. <article-title>Reactions of the immune system in epilepsy</article-title>. <source>Maedica (Bucur)</source>. <year>2010</year>;<volume>5</volume>:<fpage>201</fpage>&#8208;<lpage>206</lpage>.<pub-id pub-id-type="pmid">21977153</pub-id><pub-id pub-id-type="pmcid">PMC3177549</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="aogs14642-cit-0017"><string-name name-style="western"><surname>Stokholm</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Sevelsted</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname><given-names>UD</given-names></string-name>, <string-name name-style="western"><surname>Bisgaard</surname><given-names>H</given-names></string-name>. <article-title>Preeclampsia associates with asthma, allergy, and eczema in childhood</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2017</year>;<volume>195</volume>:<fpage>614</fpage>&#8208;<lpage>621</lpage>.<pub-id pub-id-type="pmid">27626972</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.201604-0806OC</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="aogs14642-cit-0018"><string-name name-style="western"><surname>Byberg</surname><given-names>KK</given-names></string-name>, <string-name name-style="western"><surname>Ogland</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Eide</surname><given-names>GE</given-names></string-name>, <string-name name-style="western"><surname>Oymar</surname><given-names>K</given-names></string-name>. <article-title>Birth after preeclamptic pregnancies: association with allergic sensitization and allergic rhinoconjunctivitis in late childhood; a historically matched cohort study</article-title>. <source>BMC Pediatr</source>. <year>2014</year>;<volume>14</volume>:<fpage>101</fpage>.<pub-id pub-id-type="pmid">24725676</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1471-2431-14-101</pub-id><pub-id pub-id-type="pmcid">PMC3995723</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0019"><label>19</label><mixed-citation publication-type="miscellaneous" id="aogs14642-cit-0019"><collab collab-type="authors">(NICE) NIoHaCE</collab>
. <article-title>Hypertension in pregnancy: diagnosis and management (ng133). NICE Guidelines</article-title>. <year>2019</year>.</mixed-citation></ref><ref id="aogs14642-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="aogs14642-cit-0020"><string-name name-style="western"><surname>Brown</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Magee</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Kenny</surname><given-names>LC</given-names></string-name>, et al. <article-title>Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice</article-title>. <source>Hypertension</source>. <year>2018</year>;<volume>72</volume>:<fpage>24</fpage>&#8208;<lpage>43</lpage>.<pub-id pub-id-type="pmid">29899139</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/HYPERTENSIONAHA.117.10803</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="aogs14642-cit-0021"><string-name name-style="western"><surname>Thomsen</surname><given-names>LC</given-names></string-name>, <string-name name-style="western"><surname>Klungsoyr</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Roten</surname><given-names>LT</given-names></string-name>, et al. <article-title>Validity of the diagnosis of pre&#8208;eclampsia in the medical birth registry of Norway</article-title>. <source>Acta Obstet Gynecol Scand</source>. <year>2013</year>;<volume>92</volume>:<fpage>943</fpage>&#8208;<lpage>950</lpage>.<pub-id pub-id-type="pmid">23621424</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/aogs.12159</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="aogs14642-cit-0022"><string-name name-style="western"><surname>Staff</surname><given-names>AC</given-names></string-name>. <article-title>The two&#8208;stage placental model of preeclampsia: an update</article-title>. <source>J Reprod Immunol</source>. <year>2019</year>;<volume>134&#8211;135</volume>:<fpage>1</fpage>&#8208;<lpage>10</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jri.2019.07.004</pub-id><pub-id pub-id-type="pmid">31301487</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="aogs14642-cit-0023"><string-name name-style="western"><surname>Kreiner</surname><given-names>FF</given-names></string-name>, <string-name name-style="western"><surname>Kraaijenhof</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>von Herrath</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hovingh</surname><given-names>GKK</given-names></string-name>, <string-name name-style="western"><surname>von Scholten</surname><given-names>BJ</given-names></string-name>. <article-title>Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives</article-title>. <source>Expert Rev Clin Immunol</source>. <year>2022</year>;<volume>18</volume>:<fpage>377</fpage>&#8208;<lpage>389</lpage>.<pub-id pub-id-type="pmid">35212585</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/1744666X.2022.2045952</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="aogs14642-cit-0024"><string-name name-style="western"><surname>Mohamed&#8208;Ali</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Goodrick</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Rawesh</surname><given-names>A</given-names></string-name>, et al. <article-title>Subcutaneous adipose tissue releases Interleukin&#8208;6, but not tumor necrosis factor&#8208;a, in vivo*</article-title>. <source>J Clin Endocrinol Metab</source>. <year>1997</year>;<volume>82</volume>:<fpage>4196</fpage>&#8208;<lpage>4200</lpage>.<pub-id pub-id-type="pmid">9398739</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1210/jcem.82.12.4450</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="aogs14642-cit-0025"><string-name name-style="western"><surname>Jarmund</surname><given-names>AH</given-names></string-name>, <string-name name-style="western"><surname>Giskeodegard</surname><given-names>GF</given-names></string-name>, <string-name name-style="western"><surname>Ryssdal</surname><given-names>M</given-names></string-name>, et al. <article-title>Cytokine patterns in maternal serum from first trimester to term and beyond</article-title>. <source>Front Immunol</source>. <year>2021</year>;<volume>12</volume>:<elocation-id>752660</elocation-id>.<pub-id pub-id-type="pmid">34721426</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2021.752660</pub-id><pub-id pub-id-type="pmcid">PMC8552528</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="aogs14642-cit-0026"><string-name name-style="western"><surname>Lau</surname><given-names>SY</given-names></string-name>, <string-name name-style="western"><surname>Guild</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Barrett</surname><given-names>CJ</given-names></string-name>, et al. <article-title>Tumor necrosis factor&#8208;alpha, interleukin&#8208;6, and interleukin&#8208;10 levels are altered in preeclampsia: a systematic review and meta&#8208;analysis</article-title>. <source>Am J Reprod Immunol</source>. <year>2013</year>;<volume>70</volume>:<fpage>412</fpage>&#8208;<lpage>427</lpage>.<pub-id pub-id-type="pmid">23790133</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/aji.12138</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="aogs14642-cit-0027"><string-name name-style="western"><surname>Szarka</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Rigo</surname><given-names>J</given-names><suffix>Jr</suffix></string-name>, <string-name name-style="western"><surname>Lazar</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Beko</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Molvarec</surname><given-names>A</given-names></string-name>. <article-title>Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array</article-title>. <source>BMC Immunol</source>. <year>2010</year>;<volume>11</volume>:<fpage>59</fpage>.<pub-id pub-id-type="pmid">21126355</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1471-2172-11-59</pub-id><pub-id pub-id-type="pmcid">PMC3014878</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="aogs14642-cit-0028"><string-name name-style="western"><surname>Poon</surname><given-names>LC</given-names></string-name>, <string-name name-style="western"><surname>Kametas</surname><given-names>NA</given-names></string-name>, <string-name name-style="western"><surname>Chelemen</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Leal</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Nicolaides</surname><given-names>KH</given-names></string-name>. <article-title>Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach</article-title>. <source>J Hum Hypertens</source>. <year>2010</year>;<volume>24</volume>:<fpage>104</fpage>&#8208;<lpage>110</lpage>.<pub-id pub-id-type="pmid">19516271</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/jhh.2009.45</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="aogs14642-cit-0029"><string-name name-style="western"><surname>Akolekar</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Syngelaki</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sarquis</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Zvanca</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Nicolaides</surname><given-names>KH</given-names></string-name>. <article-title>Prediction of early, intermediate and late pre&#8208;eclampsia from maternal factors, biophysical and biochemical markers at 11&#8211;13&#8201;weeks</article-title>. <source>Prenat Diagn</source>. <year>2011</year>;<volume>31</volume>(<issue>1</issue>):<fpage>66</fpage>&#8208;<lpage>74</lpage>.<pub-id pub-id-type="pmid">21210481</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/pd.2660</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="aogs14642-cit-0030"><string-name name-style="western"><surname>Robillard</surname><given-names>PY</given-names></string-name>, <string-name name-style="western"><surname>Dekker</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Scioscia</surname><given-names>M</given-names></string-name>, et al. <article-title>Validation of the 34&#8208;week gestation as definition of late onset preeclampsia: testing different cutoffs from 30 to 37&#8201;weeks on a population&#8208;based cohort of 1700 preeclamptics</article-title>. <source>Acta Obstet Gynecol Scand</source>. <year>2020</year>;<volume>99</volume>:<fpage>1181</fpage>&#8208;<lpage>1190</lpage>.<pub-id pub-id-type="pmid">32176317</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/aogs.13846</pub-id><pub-id pub-id-type="pmcid">PMC7492422</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="aogs14642-cit-0031"><string-name name-style="western"><surname>Olson</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Shu</surname><given-names>XO</given-names></string-name>, <string-name name-style="western"><surname>Ross</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Pendergrass</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Robison</surname><given-names>LL</given-names></string-name>. <article-title>Medical record validation of maternally reported birth characteristics and pregnancy&#8208;related events: a report from the Children's cancer group</article-title>. <source>Am J Epidemiol</source>. <year>1997</year>;<volume>145</volume>:<fpage>58</fpage>&#8208;<lpage>67</lpage>.<pub-id pub-id-type="pmid">8982023</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/oxfordjournals.aje.a009032</pub-id></mixed-citation></ref><ref id="aogs14642-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="aogs14642-cit-0032"><string-name name-style="western"><surname>Piccoli</surname><given-names>GB</given-names></string-name>, <string-name name-style="western"><surname>Alrukhaimi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>ZH</given-names></string-name>, <string-name name-style="western"><surname>Zakharova</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Levin</surname><given-names>A</given-names></string-name>. <article-title>World kidney day steering C. what we do and do not know about women and kidney diseases; questions unanswered and answers unquestioned: reflection on world kidney day and international Woman's day</article-title>. <source>Nefrologia (Engl ed)</source>. <year>2018</year>;<volume>38</volume>:<fpage>114</fpage>&#8208;<lpage>124</lpage>.<pub-id pub-id-type="pmid">29287946</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nefro.2017.11.009</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>